

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of superoxide anion generation (GO:0032928) | 6.29292486 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.15602446 |
| 3 | developmental pigmentation (GO:0048066) | 4.89224951 |
| 4 | melanosome organization (GO:0032438) | 4.86904543 |
| 5 | pigment granule organization (GO:0048753) | 4.78067764 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77223165 |
| 7 | regulation of early endosome to late endosome transport (GO:2000641) | 4.73233179 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71537796 |
| 9 | cellular response to reactive nitrogen species (GO:1902170) | 4.68237115 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66134856 |
| 11 | vocalization behavior (GO:0071625) | 4.65080821 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.60860652 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.53761280 |
| 14 | melanocyte differentiation (GO:0030318) | 4.51553794 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.51286059 |
| 16 | synaptic vesicle maturation (GO:0016188) | 4.48080768 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44774771 |
| 18 | pigment cell differentiation (GO:0050931) | 4.42620177 |
| 19 | positive regulation of receptor recycling (GO:0001921) | 4.30047988 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.28558281 |
| 21 | glutamate secretion (GO:0014047) | 4.27539758 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.27237552 |
| 23 | protein localization to synapse (GO:0035418) | 4.27033266 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.22677399 |
| 25 | phenol-containing compound biosynthetic process (GO:0046189) | 4.21992260 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.18273773 |
| 27 | stress fiber assembly (GO:0043149) | 4.18256538 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.11035220 |
| 29 | pigment biosynthetic process (GO:0046148) | 4.10711867 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.09852867 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 4.05923028 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.96372880 |
| 33 | regulation of superoxide metabolic process (GO:0090322) | 3.96179113 |
| 34 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.94190493 |
| 35 | retinal rod cell development (GO:0046548) | 3.91933560 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91213405 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.89269049 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.89001412 |
| 39 | neurotransmitter secretion (GO:0007269) | 3.85001084 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.78244312 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 3.75794076 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.70598008 |
| 43 | neuron recognition (GO:0008038) | 3.69412536 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.67022395 |
| 45 | glutamate receptor signaling pathway (GO:0007215) | 3.65374488 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.62486528 |
| 47 | response to thyroid hormone (GO:0097066) | 3.61363134 |
| 48 | response to epinephrine (GO:0071871) | 3.58545566 |
| 49 | pigment metabolic process (GO:0042440) | 3.57130912 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54415959 |
| 51 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.53764372 |
| 52 | locomotory exploration behavior (GO:0035641) | 3.53052354 |
| 53 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.48443369 |
| 54 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.41433761 |
| 55 | barbed-end actin filament capping (GO:0051016) | 3.41201498 |
| 56 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41143001 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.39829246 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.39654301 |
| 59 | exploration behavior (GO:0035640) | 3.38522661 |
| 60 | presynaptic membrane assembly (GO:0097105) | 3.36491527 |
| 61 | pinocytosis (GO:0006907) | 3.33952204 |
| 62 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.32643485 |
| 63 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.32643485 |
| 64 | axonal fasciculation (GO:0007413) | 3.31356556 |
| 65 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.31061985 |
| 66 | presynaptic membrane organization (GO:0097090) | 3.30499195 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 3.30471663 |
| 68 | protein localization to endosome (GO:0036010) | 3.29778728 |
| 69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.28664437 |
| 70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.27176442 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.26452840 |
| 72 | negative regulation of interleukin-1 production (GO:0032692) | 3.25487908 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.24959634 |
| 74 | response to histamine (GO:0034776) | 3.24838790 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.24510970 |
| 76 | neurotransmitter transport (GO:0006836) | 3.24104755 |
| 77 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.21772142 |
| 78 | striatum development (GO:0021756) | 3.20725832 |
| 79 | mannose metabolic process (GO:0006013) | 3.17287591 |
| 80 | negative regulation of chemokine production (GO:0032682) | 3.16614373 |
| 81 | negative regulation of necroptotic process (GO:0060546) | 3.16083053 |
| 82 | positive regulation of membrane potential (GO:0045838) | 3.15286562 |
| 83 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.13879801 |
| 84 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.13691294 |
| 85 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12835506 |
| 86 | long-term memory (GO:0007616) | 3.12650474 |
| 87 | secondary metabolic process (GO:0019748) | 3.10718641 |
| 88 | behavioral response to cocaine (GO:0048148) | 3.10008139 |
| 89 | fructose metabolic process (GO:0006000) | 3.09713192 |
| 90 | regulation of glutamate secretion (GO:0014048) | 3.09519191 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.09285283 |
| 92 | transmission of nerve impulse (GO:0019226) | 3.08671603 |
| 93 | layer formation in cerebral cortex (GO:0021819) | 3.07268611 |
| 94 | long-term synaptic potentiation (GO:0060291) | 3.05804474 |
| 95 | negative regulation of microtubule polymerization (GO:0031115) | 3.05381446 |
| 96 | regulation of neurotransmitter secretion (GO:0046928) | 3.02722801 |
| 97 | synaptic vesicle endocytosis (GO:0048488) | 3.01416012 |
| 98 | regulation of cell communication by electrical coupling (GO:0010649) | 3.01180985 |
| 99 | cerebellar granule cell differentiation (GO:0021707) | 2.99874475 |
| 100 | positive regulation of synapse maturation (GO:0090129) | 2.99657594 |
| 101 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.98795747 |
| 102 | regulation of necroptotic process (GO:0060544) | 2.97482752 |
| 103 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96732673 |
| 104 | proline transport (GO:0015824) | 2.96179099 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95060536 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.94478500 |
| 107 | transferrin transport (GO:0033572) | 2.94365256 |
| 108 | negative regulation of acute inflammatory response (GO:0002674) | 2.94118048 |
| 109 | postsynaptic membrane organization (GO:0001941) | 2.92141847 |
| 110 | regulation of neurotransmitter levels (GO:0001505) | 2.91793660 |
| 111 | regulation of neurotransmitter transport (GO:0051588) | 2.91558319 |
| 112 | NADH metabolic process (GO:0006734) | 2.90710094 |
| 113 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.89974557 |
| 114 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.89974557 |
| 115 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.89102504 |
| 116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.89070749 |
| 117 | regulation of synaptic plasticity (GO:0048167) | 2.88622360 |
| 118 | chaperone-mediated protein transport (GO:0072321) | 2.88523274 |
| 119 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.88086905 |
| 120 | establishment of mitochondrion localization (GO:0051654) | 2.87286533 |
| 121 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.87049192 |
| 122 | dendritic spine morphogenesis (GO:0060997) | 2.86769393 |
| 123 | membrane hyperpolarization (GO:0060081) | 2.85598055 |
| 124 | membrane depolarization (GO:0051899) | 2.85395797 |
| 125 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85148538 |
| 126 | positive regulation of neurotransmitter transport (GO:0051590) | 2.84458282 |
| 127 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.84420012 |
| 128 | adult walking behavior (GO:0007628) | 2.84316162 |
| 129 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82781121 |
| 130 | cell migration in hindbrain (GO:0021535) | 2.82358744 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81744075 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.81744075 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81744075 |
| 134 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81744075 |
| 135 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81744075 |
| 136 | modulation by symbiont of host immune response (GO:0052553) | 2.81744075 |
| 137 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.81541292 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.81428679 |
| 139 | organelle transport along microtubule (GO:0072384) | 2.81386042 |
| 140 | detection of calcium ion (GO:0005513) | 2.80557158 |
| 141 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.80431956 |
| 142 | synaptic transmission (GO:0007268) | 2.79644677 |
| 143 | synapse assembly (GO:0007416) | 2.79263896 |
| 144 | activation of protein kinase A activity (GO:0034199) | 2.78593978 |
| 145 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.78400617 |
| 146 | learning (GO:0007612) | 2.78209763 |
| 147 | cellular potassium ion homeostasis (GO:0030007) | 2.77045528 |
| 148 | synaptic transmission, dopaminergic (GO:0001963) | 2.76049067 |
| 149 | ATP synthesis coupled proton transport (GO:0015986) | 2.76002836 |
| 150 | cellular response to nitric oxide (GO:0071732) | 2.75300503 |
| 151 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.73398484 |
| 152 | detection of bacterium (GO:0016045) | 2.69532871 |
| 153 | ketone body metabolic process (GO:1902224) | 2.68311922 |
| 154 | regulation of receptor recycling (GO:0001919) | 2.68061177 |
| 155 | pyrimidine nucleoside salvage (GO:0043097) | 2.67434866 |
| 156 | pyrimidine-containing compound salvage (GO:0008655) | 2.67434866 |
| 157 | negative regulation of cell killing (GO:0031342) | 2.67282606 |
| 158 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67282606 |
| 159 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64654265 |
| 160 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64279743 |
| 161 | gluconeogenesis (GO:0006094) | 2.64005865 |
| 162 | Golgi transport vesicle coating (GO:0048200) | 2.63162862 |
| 163 | COPI coating of Golgi vesicle (GO:0048205) | 2.63162862 |
| 164 | detection of other organism (GO:0098543) | 2.62206258 |
| 165 | glycosphingolipid catabolic process (GO:0046479) | 2.60086305 |
| 166 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59427562 |
| 167 | regulation of necrotic cell death (GO:0010939) | 2.53383946 |
| 168 | monosaccharide biosynthetic process (GO:0046364) | 2.53016248 |
| 169 | hexose biosynthetic process (GO:0019319) | 2.51845398 |
| 170 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.51764935 |
| 171 | cellular response to epinephrine stimulus (GO:0071872) | 2.50137895 |
| 172 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.48840638 |
| 173 | glucose 6-phosphate metabolic process (GO:0051156) | 2.48488988 |
| 174 | negative regulation of myotube differentiation (GO:0010832) | 2.48213176 |
| 175 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.47103544 |
| 176 | neutrophil activation involved in immune response (GO:0002283) | 2.46111312 |
| 177 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.42913981 |
| 178 | neuroepithelial cell differentiation (GO:0060563) | 2.42751652 |
| 179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42347272 |
| 180 | hepatocyte apoptotic process (GO:0097284) | 2.41327242 |
| 181 | positive regulation of antigen processing and presentation (GO:0002579) | 2.40650940 |
| 182 | positive thymic T cell selection (GO:0045059) | 2.40216756 |
| 183 | activation of JUN kinase activity (GO:0007257) | 2.39624075 |
| 184 | negative regulation of organelle assembly (GO:1902116) | 2.39432153 |
| 185 | response to muramyl dipeptide (GO:0032495) | 2.38601187 |
| 186 | phospholipid dephosphorylation (GO:0046839) | 2.38515606 |
| 187 | negative regulation of necrotic cell death (GO:0060547) | 2.37611476 |
| 188 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.37385843 |
| 189 | glycolipid catabolic process (GO:0019377) | 2.36456475 |
| 190 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.35960260 |
| 191 | macrophage activation involved in immune response (GO:0002281) | 2.35657622 |
| 192 | glucose catabolic process (GO:0006007) | 2.34879084 |
| 193 | negative regulation of TOR signaling (GO:0032007) | 2.34591689 |
| 194 | response to peptidoglycan (GO:0032494) | 2.34256904 |
| 195 | pentose-phosphate shunt (GO:0006098) | 2.34095717 |
| 196 | response to parathyroid hormone (GO:0071107) | 2.32407686 |
| 197 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.32392790 |
| 198 | melanin biosynthetic process (GO:0042438) | 13.3357049 |
| 199 | melanin metabolic process (GO:0006582) | 12.4681424 |
| 200 | secondary metabolite biosynthetic process (GO:0044550) | 10.7826603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.00848584 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.20813359 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13177971 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09295678 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99376107 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77662250 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.51140020 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49619854 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48961998 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46207148 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45406629 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40512080 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40512080 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38734018 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37798590 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37498297 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36865163 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29483834 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29391025 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28449789 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24601139 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23243064 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21557924 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21457471 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18813592 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16363893 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.15956993 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14797102 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.14249063 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13508138 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.11795799 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10528596 |
| 33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.10410441 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.09143896 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07650302 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00423766 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99089688 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98655927 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97579794 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96003814 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95833173 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94496317 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90026970 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89902755 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86567013 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86097581 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81573156 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81331882 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81205790 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80582942 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79972209 |
| 52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79890562 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79207219 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77303923 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76575632 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75608193 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75533849 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74501024 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68659664 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66094040 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65603216 |
| 62 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65570842 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.64175938 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64021988 |
| 65 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63620645 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62872851 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62182041 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60906434 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59783704 |
| 70 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.58784185 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.58673944 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55791423 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54083954 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53501862 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52882810 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49087883 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48087924 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47592642 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47401885 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46618788 |
| 81 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45520499 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44875413 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44038505 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43971442 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42766142 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41351968 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39885261 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39035703 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38616537 |
| 90 | * P68_20966046_ChIP-Seq_HELA_Human | 1.37978694 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37580107 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37391713 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37294448 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36784016 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36110717 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34747756 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33567212 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32997817 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32514094 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 1.32419939 |
| 101 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32317160 |
| 102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31413273 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30809612 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29763883 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28784425 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28727256 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27999036 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27866869 |
| 109 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.27401778 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27282385 |
| 111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26950269 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26820597 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26496057 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26239301 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25933572 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25281595 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25198560 |
| 118 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24555312 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24497715 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24208637 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24180385 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24151600 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23657624 |
| 124 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23647268 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23281586 |
| 126 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21932657 |
| 127 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21701274 |
| 128 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21509963 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21069352 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19028858 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18462711 |
| 132 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18091490 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17948448 |
| 134 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17804524 |
| 135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16981915 |
| 136 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16880606 |
| 137 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.16820838 |
| 138 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15677604 |
| 139 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15537402 |
| 140 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15509162 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14867776 |
| 142 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13855033 |
| 143 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13717051 |
| 144 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13277648 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13171935 |
| 146 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12953672 |
| 147 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12156876 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11710122 |
| 149 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.10821477 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10511206 |
| 151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10464176 |
| 152 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09467986 |
| 153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09370778 |
| 154 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.09355468 |
| 155 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08761012 |
| 156 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08447893 |
| 157 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.07747407 |
| 158 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07294312 |
| 159 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06900870 |
| 160 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06713175 |
| 161 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06433225 |
| 162 | JUN_21703547_ChIP-Seq_K562_Human | 1.05984933 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05851679 |
| 164 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05631953 |
| 165 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05247030 |
| 166 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05165088 |
| 167 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04654896 |
| 168 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04551749 |
| 169 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04085120 |
| 170 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03842714 |
| 171 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03808205 |
| 172 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03224795 |
| 173 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03174020 |
| 174 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02911432 |
| 175 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02471700 |
| 176 | MYB_26560356_Chip-Seq_TH1_Human | 1.02168558 |
| 177 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02089791 |
| 178 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01720095 |
| 179 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01301123 |
| 180 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01208665 |
| 181 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01114264 |
| 182 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00962566 |
| 183 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00741691 |
| 184 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99258630 |
| 185 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98643705 |
| 186 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98333021 |
| 187 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.98082003 |
| 188 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97569592 |
| 189 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97566478 |
| 190 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97566478 |
| 191 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97253664 |
| 192 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93876474 |
| 193 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91774889 |
| 194 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90510175 |
| 195 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90159779 |
| 196 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89521384 |
| 197 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89498129 |
| 198 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.88221334 |
| 199 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87626836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 7.59256938 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.10120905 |
| 3 | MP0003880_abnormal_central_pattern | 5.06203768 |
| 4 | MP0005408_hypopigmentation | 4.99041377 |
| 5 | MP0005075_abnormal_melanosome_morpholog | 4.81093663 |
| 6 | MP0000015_abnormal_ear_pigmentation | 4.56101963 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 4.13527898 |
| 8 | MP0003136_yellow_coat_color | 3.91839797 |
| 9 | MP0004381_abnormal_hair_follicle | 3.70952873 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.65077594 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.57316245 |
| 12 | MP0004270_analgesia | 3.52235886 |
| 13 | MP0009745_abnormal_behavioral_response | 3.24843353 |
| 14 | MP0000371_diluted_coat_color | 3.09058684 |
| 15 | MP0002064_seizures | 3.07574650 |
| 16 | MP0002063_abnormal_learning/memory/cond | 3.04328245 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.91366515 |
| 18 | MP0009046_muscle_twitch | 2.89720553 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.72846851 |
| 20 | MP0002095_abnormal_skin_pigmentation | 2.70812920 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.67504067 |
| 22 | MP0002272_abnormal_nervous_system | 2.62412516 |
| 23 | MP0002736_abnormal_nociception_after | 2.56744176 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.54820120 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.51980648 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.49604319 |
| 27 | MP0005058_abnormal_lysosome_morphology | 2.48933062 |
| 28 | MP0001486_abnormal_startle_reflex | 2.38992060 |
| 29 | MP0002822_catalepsy | 2.37901986 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 2.37327813 |
| 31 | MP0005174_abnormal_tail_pigmentation | 2.30178814 |
| 32 | MP0001529_abnormal_vocalization | 2.21607169 |
| 33 | MP0005451_abnormal_body_composition | 2.15362971 |
| 34 | MP0001440_abnormal_grooming_behavior | 2.11396575 |
| 35 | MP0006276_abnormal_autonomic_nervous | 2.10290519 |
| 36 | MP0005409_darkened_coat_color | 2.05146407 |
| 37 | MP0005423_abnormal_somatic_nervous | 2.02039585 |
| 38 | MP0002067_abnormal_sensory_capabilities | 2.00918842 |
| 39 | MP0001970_abnormal_pain_threshold | 1.97805005 |
| 40 | MP0000778_abnormal_nervous_system | 1.97424910 |
| 41 | MP0001905_abnormal_dopamine_level | 1.93251756 |
| 42 | MP0000751_myopathy | 1.91844317 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.86362193 |
| 44 | MP0003329_amyloid_beta_deposits | 1.85557099 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.83937481 |
| 46 | MP0003122_maternal_imprinting | 1.83512417 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.82113281 |
| 48 | MP0001324_abnormal_eye_pigmentation | 1.81486904 |
| 49 | MP0002075_abnormal_coat/hair_pigmentati | 1.79718028 |
| 50 | MP0001984_abnormal_olfaction | 1.75287748 |
| 51 | MP0004924_abnormal_behavior | 1.73557620 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.73557620 |
| 53 | MP0002184_abnormal_innervation | 1.72430558 |
| 54 | MP0008260_abnormal_autophagy | 1.67806464 |
| 55 | MP0003436_decreased_susceptibility_to | 1.67118690 |
| 56 | MP0003787_abnormal_imprinting | 1.64414394 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.62096142 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.60332008 |
| 59 | MP0008569_lethality_at_weaning | 1.58799554 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.54719709 |
| 61 | MP0001186_pigmentation_phenotype | 1.53458688 |
| 62 | MP0004142_abnormal_muscle_tone | 1.51565743 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.51528179 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.51072030 |
| 65 | MP0003878_abnormal_ear_physiology | 1.50668265 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.50668265 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.43904219 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.40042148 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.38192927 |
| 70 | MP0005257_abnormal_intraocular_pressure | 1.37789081 |
| 71 | MP0000955_abnormal_spinal_cord | 1.35660835 |
| 72 | MP0003303_peritoneal_inflammation | 1.34291333 |
| 73 | MP0004145_abnormal_muscle_electrophysio | 1.33474427 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.27448801 |
| 75 | MP0009840_abnormal_foam_cell | 1.23131483 |
| 76 | MP0004036_abnormal_muscle_relaxation | 1.22991391 |
| 77 | MP0000920_abnormal_myelination | 1.22754460 |
| 78 | MP0003633_abnormal_nervous_system | 1.22363900 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.17666289 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.16468348 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.16348855 |
| 82 | MP0002229_neurodegeneration | 1.15083561 |
| 83 | MP0001835_abnormal_antigen_presentation | 1.14670537 |
| 84 | MP0003879_abnormal_hair_cell | 1.14515881 |
| 85 | MP0003763_abnormal_thymus_physiology | 1.14016216 |
| 86 | MP0004085_abnormal_heartbeat | 1.10661085 |
| 87 | MP0003631_nervous_system_phenotype | 1.08882129 |
| 88 | MP0000749_muscle_degeneration | 1.07133824 |
| 89 | MP0003137_abnormal_impulse_conducting | 1.06512226 |
| 90 | MP0004484_altered_response_of | 1.05991273 |
| 91 | MP0004084_abnormal_cardiac_muscle | 1.05360789 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.05257129 |
| 93 | MP0004742_abnormal_vestibular_system | 1.03465013 |
| 94 | MP0005076_abnormal_cell_differentiation | 1.03038325 |
| 95 | MP0005248_abnormal_Harderian_gland | 1.01664527 |
| 96 | MP0003634_abnormal_glial_cell | 0.99560360 |
| 97 | MP0003866_abnormal_defecation | 0.99165939 |
| 98 | MP0001188_hyperpigmentation | 0.99062684 |
| 99 | MP0001502_abnormal_circadian_rhythm | 0.97827725 |
| 100 | MP0002419_abnormal_innate_immunity | 0.97658330 |
| 101 | MP0003646_muscle_fatigue | 0.97554558 |
| 102 | MP0005025_abnormal_response_to | 0.95690288 |
| 103 | MP0004858_abnormal_nervous_system | 0.95607675 |
| 104 | MP0000685_abnormal_immune_system | 0.94238030 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.93082407 |
| 106 | MP0002152_abnormal_brain_morphology | 0.92337079 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.90541057 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 0.88628773 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.88444549 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.88348264 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.88084998 |
| 112 | MP0004885_abnormal_endolymph | 0.87742198 |
| 113 | MP0003690_abnormal_glial_cell | 0.87103156 |
| 114 | MP0005387_immune_system_phenotype | 0.87015883 |
| 115 | MP0001790_abnormal_immune_system | 0.87015883 |
| 116 | MP0006138_congestive_heart_failure | 0.86942762 |
| 117 | MP0001800_abnormal_humoral_immune | 0.85644529 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.85506225 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.85061005 |
| 120 | MP0005171_absent_coat_pigmentation | 0.84889740 |
| 121 | MP0002090_abnormal_vision | 0.84534255 |
| 122 | MP0003632_abnormal_nervous_system | 0.82631486 |
| 123 | MP0001177_atelectasis | 0.81834937 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.79554465 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.79258703 |
| 126 | MP0000569_abnormal_digit_pigmentation | 0.78723283 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.78707557 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.78520353 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.78462059 |
| 130 | MP0000604_amyloidosis | 0.77699294 |
| 131 | MP0002972_abnormal_cardiac_muscle | 0.77508369 |
| 132 | MP0005535_abnormal_body_temperature | 0.77058933 |
| 133 | MP0001851_eye_inflammation | 0.76156515 |
| 134 | MP0002723_abnormal_immune_serum | 0.75953062 |
| 135 | MP0002420_abnormal_adaptive_immunity | 0.75840960 |
| 136 | MP0000747_muscle_weakness | 0.75672772 |
| 137 | MP0005623_abnormal_meninges_morphology | 0.75555025 |
| 138 | MP0001819_abnormal_immune_cell | 0.75545014 |
| 139 | MP0004947_skin_inflammation | 0.75053247 |
| 140 | MP0001849_ear_inflammation | 0.74437178 |
| 141 | MP0002102_abnormal_ear_morphology | 0.74306326 |
| 142 | MP0003121_genomic_imprinting | 0.73816659 |
| 143 | MP0001299_abnormal_eye_distance/ | 0.73497158 |
| 144 | MP0003724_increased_susceptibility_to | 0.73480069 |
| 145 | MP0002452_abnormal_antigen_presenting | 0.72868375 |
| 146 | MP0005671_abnormal_response_to | 0.72496127 |
| 147 | MP0004510_myositis | 0.72460103 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.71429128 |
| 149 | MP0004130_abnormal_muscle_cell | 0.71062616 |
| 150 | MP0009333_abnormal_splenocyte_physiolog | 0.70676099 |
| 151 | MP0002398_abnormal_bone_marrow | 0.70199817 |
| 152 | MP0008872_abnormal_physiological_respon | 0.70048769 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.69968373 |
| 154 | MP0005253_abnormal_eye_physiology | 0.69580389 |
| 155 | MP0006072_abnormal_retinal_apoptosis | 0.68965232 |
| 156 | MP0006035_abnormal_mitochondrial_morpho | 0.68817045 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.67591090 |
| 158 | MP0001533_abnormal_skeleton_physiology | 0.66534021 |
| 159 | MP0005197_abnormal_uvea_morphology | 0.66462304 |
| 160 | MP0004233_abnormal_muscle_weight | 0.64032636 |
| 161 | MP0005645_abnormal_hypothalamus_physiol | 0.62766137 |
| 162 | MP0000367_abnormal_coat/_hair | 0.62037999 |
| 163 | MP0001943_abnormal_respiration | 0.60430769 |
| 164 | MP0000716_abnormal_immune_system | 0.60363722 |
| 165 | MP0001986_abnormal_taste_sensitivity | 0.59436186 |
| 166 | MP0006036_abnormal_mitochondrial_physio | 0.58662809 |
| 167 | MP0004808_abnormal_hematopoietic_stem | 0.58555177 |
| 168 | MP0008874_decreased_physiological_sensi | 0.58148256 |
| 169 | MP0001845_abnormal_inflammatory_respons | 0.57410048 |
| 170 | MP0000343_altered_response_to | 0.56384161 |
| 171 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56089216 |
| 172 | MP0005083_abnormal_biliary_tract | 0.55780351 |
| 173 | MP0002429_abnormal_blood_cell | 0.55752490 |
| 174 | MP0009115_abnormal_fat_cell | 0.55310471 |
| 175 | MP0002971_abnormal_brown_adipose | 0.54659132 |
| 176 | MP0005319_abnormal_enzyme/_coenzyme | 0.53951500 |
| 177 | MP0001873_stomach_inflammation | 0.53769066 |
| 178 | MP0009278_abnormal_bone_marrow | 0.53463660 |
| 179 | MP0000703_abnormal_thymus_morphology | 0.52926001 |
| 180 | MP0009643_abnormal_urine_homeostasis | 0.51928030 |
| 181 | MP0002722_abnormal_immune_system | 0.51087961 |
| 182 | MP0005360_urolithiasis | 0.51011518 |
| 183 | MP0000609_abnormal_liver_physiology | 0.50864312 |
| 184 | MP0000465_gastrointestinal_hemorrhage | 0.50544864 |
| 185 | MP0000689_abnormal_spleen_morphology | 0.50476924 |
| 186 | MP0004043_abnormal_pH_regulation | 0.49212885 |
| 187 | MP0009785_altered_susceptibility_to | 0.49110425 |
| 188 | MP0008469_abnormal_protein_level | 0.47919015 |
| 189 | MP0005166_decreased_susceptibility_to | 0.47819315 |
| 190 | MP0005621_abnormal_cell_physiology | 0.47591870 |
| 191 | MP0005670_abnormal_white_adipose | 0.47344481 |
| 192 | MP0000490_abnormal_crypts_of | 0.46879519 |
| 193 | MP0005165_increased_susceptibility_to | 0.46528210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ocular albinism (HP:0001107) | 8.30426968 |
| 2 | Iris hypopigmentation (HP:0007730) | 7.05490644 |
| 3 | Focal motor seizures (HP:0011153) | 6.69547194 |
| 4 | Aplasia/Hypoplasia of the macula (HP:0008059) | 6.25103598 |
| 5 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.73834138 |
| 6 | Blue irides (HP:0000635) | 5.12317923 |
| 7 | Myokymia (HP:0002411) | 5.04083135 |
| 8 | Focal seizures (HP:0007359) | 4.48491251 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.39457571 |
| 10 | White forelock (HP:0002211) | 4.38675127 |
| 11 | Atonic seizures (HP:0010819) | 4.24871767 |
| 12 | Patchy hypopigmentation of hair (HP:0011365) | 4.10520090 |
| 13 | Hypoplasia of the fovea (HP:0007750) | 3.99028591 |
| 14 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.99028591 |
| 15 | Visual hallucinations (HP:0002367) | 3.96318946 |
| 16 | Hypopigmentation of the fundus (HP:0007894) | 3.94948514 |
| 17 | Febrile seizures (HP:0002373) | 3.93733730 |
| 18 | Generalized hypopigmentation (HP:0007513) | 3.84208984 |
| 19 | Pheochromocytoma (HP:0002666) | 3.73388874 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.48883445 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.42247390 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 3.41787268 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.39358848 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37340398 |
| 25 | Albinism (HP:0001022) | 3.33824581 |
| 26 | Hyperventilation (HP:0002883) | 3.33513584 |
| 27 | Absence seizures (HP:0002121) | 3.31595178 |
| 28 | Termporal pattern (HP:0011008) | 3.31173118 |
| 29 | Insidious onset (HP:0003587) | 3.31173118 |
| 30 | Cholecystitis (HP:0001082) | 3.29694304 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 3.29694304 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 3.26697220 |
| 33 | Abnormality of the fovea (HP:0000493) | 3.16330313 |
| 34 | Dialeptic seizures (HP:0011146) | 3.10757612 |
| 35 | Progressive macrocephaly (HP:0004481) | 3.10611444 |
| 36 | Freckling (HP:0001480) | 3.06550151 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 3.03750995 |
| 38 | Increased serum pyruvate (HP:0003542) | 3.02907086 |
| 39 | Abnormality of glycolysis (HP:0004366) | 3.02907086 |
| 40 | Progressive inability to walk (HP:0002505) | 3.02831179 |
| 41 | Broad-based gait (HP:0002136) | 2.98187835 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.91587645 |
| 43 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.91587645 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 2.91165747 |
| 45 | Decreased central vision (HP:0007663) | 2.89552239 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.89377996 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.89377996 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.89377996 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89177062 |
| 50 | Truncal ataxia (HP:0002078) | 2.88263976 |
| 51 | Limb dystonia (HP:0002451) | 2.87126080 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.86461103 |
| 53 | Gait imbalance (HP:0002141) | 2.81327208 |
| 54 | Cutaneous melanoma (HP:0012056) | 2.81157176 |
| 55 | Mitochondrial inheritance (HP:0001427) | 2.80494446 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.78284797 |
| 57 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.70103652 |
| 58 | Urinary urgency (HP:0000012) | 2.69608242 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.65507852 |
| 60 | Anxiety (HP:0000739) | 2.65118997 |
| 61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.65050164 |
| 62 | Abnormal hair whorl (HP:0010721) | 2.61091429 |
| 63 | Depression (HP:0000716) | 2.56904826 |
| 64 | Spastic gait (HP:0002064) | 2.56510793 |
| 65 | Action tremor (HP:0002345) | 2.55588993 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.55336515 |
| 67 | Dysmetria (HP:0001310) | 2.55010040 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.54999869 |
| 69 | Acute encephalopathy (HP:0006846) | 2.54441777 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.51489672 |
| 71 | Central scotoma (HP:0000603) | 2.50123905 |
| 72 | Horizontal nystagmus (HP:0000666) | 2.48510409 |
| 73 | Ankle clonus (HP:0011448) | 2.48032301 |
| 74 | Frequent falls (HP:0002359) | 2.47898699 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.45643841 |
| 76 | Drooling (HP:0002307) | 2.44113183 |
| 77 | Excessive salivation (HP:0003781) | 2.44113183 |
| 78 | Mutism (HP:0002300) | 2.43569688 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.42920410 |
| 80 | Increased CSF lactate (HP:0002490) | 2.41860090 |
| 81 | Poor eye contact (HP:0000817) | 2.41599733 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.41382438 |
| 83 | Recurrent abscess formation (HP:0002722) | 2.39554284 |
| 84 | Optic disc pallor (HP:0000543) | 2.39453828 |
| 85 | Loss of speech (HP:0002371) | 2.39178822 |
| 86 | Amblyopia (HP:0000646) | 2.38511004 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.35090529 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35090529 |
| 89 | Abnormal eating behavior (HP:0100738) | 2.33634738 |
| 90 | Leukodystrophy (HP:0002415) | 2.32926586 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.31166000 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31104315 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30743563 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30743563 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30743563 |
| 96 | Neurofibrillary tangles (HP:0002185) | 2.30739112 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.30505362 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30439717 |
| 99 | Lower limb muscle weakness (HP:0007340) | 2.29995395 |
| 100 | Increased connective tissue (HP:0009025) | 2.29942074 |
| 101 | Abnormality of binocular vision (HP:0011514) | 2.29672528 |
| 102 | Diplopia (HP:0000651) | 2.29672528 |
| 103 | Malnutrition (HP:0004395) | 2.26980690 |
| 104 | Exercise-induced myalgia (HP:0003738) | 2.26872427 |
| 105 | Premature graying of hair (HP:0002216) | 2.18288259 |
| 106 | Abnormal auditory evoked potentials (HP:0006958) | 2.17917076 |
| 107 | Fatigue (HP:0012378) | 2.17268238 |
| 108 | Epileptiform EEG discharges (HP:0011182) | 2.16241211 |
| 109 | Impaired social interactions (HP:0000735) | 2.15637440 |
| 110 | Abnormal social behavior (HP:0012433) | 2.15637440 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 2.14974053 |
| 112 | Scanning speech (HP:0002168) | 2.14221413 |
| 113 | Vertebral compression fractures (HP:0002953) | 2.12772407 |
| 114 | Dysmetric saccades (HP:0000641) | 2.12644015 |
| 115 | Petechiae (HP:0000967) | 2.11920406 |
| 116 | Colitis (HP:0002583) | 2.11502598 |
| 117 | Subaortic stenosis (HP:0001682) | 2.11048372 |
| 118 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11048372 |
| 119 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.10823551 |
| 120 | Inability to walk (HP:0002540) | 2.09821335 |
| 121 | Polyphagia (HP:0002591) | 2.08835175 |
| 122 | Heterochromia iridis (HP:0001100) | 2.08588295 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 2.07840827 |
| 124 | Genital tract atresia (HP:0001827) | 2.03736268 |
| 125 | Thin bony cortex (HP:0002753) | 2.00445111 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00442703 |
| 127 | Vaginal atresia (HP:0000148) | 1.99944684 |
| 128 | Hypoplasia of the brainstem (HP:0002365) | 1.99890810 |
| 129 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.99890810 |
| 130 | Agitation (HP:0000713) | 1.99780620 |
| 131 | Specific learning disability (HP:0001328) | 1.99547397 |
| 132 | Increased IgE level (HP:0003212) | 1.98887017 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.97422633 |
| 134 | Abnormality of macrophages (HP:0004311) | 1.96789088 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.96458487 |
| 136 | Systemic lupus erythematosus (HP:0002725) | 1.96351209 |
| 137 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.93915957 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93866706 |
| 139 | Sudden death (HP:0001699) | 1.93752761 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.93707714 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.93235434 |
| 142 | Broad face (HP:0000283) | 1.92558795 |
| 143 | Genetic anticipation (HP:0003743) | 1.92250398 |
| 144 | Gingivitis (HP:0000230) | 1.92182205 |
| 145 | Bradykinesia (HP:0002067) | 1.91634241 |
| 146 | Psychosis (HP:0000709) | 1.91588615 |
| 147 | Gastrointestinal stroma tumor (HP:0100723) | 1.91033824 |
| 148 | Shoulder girdle muscle weakness (HP:0003547) | 1.90954605 |
| 149 | Abnormality of pain sensation (HP:0010832) | 1.90203872 |
| 150 | Impaired pain sensation (HP:0007328) | 1.90203872 |
| 151 | Gastrointestinal inflammation (HP:0004386) | 1.89959030 |
| 152 | Cerebral aneurysm (HP:0004944) | 1.88339225 |
| 153 | Calf muscle hypertrophy (HP:0008981) | 1.87969288 |
| 154 | Hypsarrhythmia (HP:0002521) | 1.87245269 |
| 155 | Abnormality of the lower motor neuron (HP:0002366) | 1.87209695 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.86967021 |
| 157 | Muscle fibrillation (HP:0010546) | 1.86456598 |
| 158 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86299427 |
| 159 | Cellulitis (HP:0100658) | 1.85222242 |
| 160 | Generalized myoclonic seizures (HP:0002123) | 1.84645381 |
| 161 | Hypoplasia of the iris (HP:0007676) | 1.84459285 |
| 162 | Abnormality of saccadic eye movements (HP:0000570) | 1.84402375 |
| 163 | Focal dystonia (HP:0004373) | 1.84333806 |
| 164 | Impaired vibratory sensation (HP:0002495) | 1.84281469 |
| 165 | Abnormality of the calf musculature (HP:0001430) | 1.83582073 |
| 166 | Torticollis (HP:0000473) | 1.83500051 |
| 167 | Fetal akinesia sequence (HP:0001989) | 1.83050390 |
| 168 | Failure to thrive in infancy (HP:0001531) | 1.81613030 |
| 169 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.79461989 |
| 170 | J-shaped sella turcica (HP:0002680) | 1.78484105 |
| 171 | Hypokinesia (HP:0002375) | 1.78399893 |
| 172 | Tongue fasciculations (HP:0001308) | 1.77095097 |
| 173 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76129576 |
| 174 | Abdominal distention (HP:0003270) | 1.74400901 |
| 175 | Myopathic facies (HP:0002058) | 1.73992779 |
| 176 | Esophageal neoplasm (HP:0100751) | 1.71729050 |
| 177 | Neoplasm of head and neck (HP:0012288) | 1.71729050 |
| 178 | Hyperactive renin-angiotensin system (HP:0000841) | 1.68221668 |
| 179 | Inflammation of the large intestine (HP:0002037) | 1.67430095 |
| 180 | Cholelithiasis (HP:0001081) | 1.65339366 |
| 181 | Distal lower limb amyotrophy (HP:0008944) | 1.64909739 |
| 182 | Pustule (HP:0200039) | 1.64600777 |
| 183 | Meningitis (HP:0001287) | 1.64421189 |
| 184 | Interstitial pulmonary disease (HP:0006530) | 1.60752924 |
| 185 | Viral hepatitis (HP:0006562) | 1.60390932 |
| 186 | Ulnar bowing (HP:0003031) | 1.60130394 |
| 187 | Hyperparathyroidism (HP:0000843) | 1.57914615 |
| 188 | Hyperacusis (HP:0010780) | 1.56476723 |
| 189 | Recurrent fungal infections (HP:0002841) | 1.55857525 |
| 190 | Purpura (HP:0000979) | 1.55771947 |
| 191 | Osteomyelitis (HP:0002754) | 1.55555468 |
| 192 | Neuronal loss in central nervous system (HP:0002529) | 1.54189433 |
| 193 | Progressive neurologic deterioration (HP:0002344) | 1.54097079 |
| 194 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.54008897 |
| 195 | Growth hormone excess (HP:0000845) | 1.53913835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 3.98785975 |
| 2 | CASK | 3.41992010 |
| 3 | NTRK3 | 3.40036745 |
| 4 | MAP3K4 | 3.30824402 |
| 5 | MAP2K7 | 3.20651190 |
| 6 | TRIB3 | 3.15920880 |
| 7 | ERN1 | 3.14332728 |
| 8 | MARK1 | 3.03715211 |
| 9 | MAP3K12 | 2.94897517 |
| 10 | EPHA4 | 2.94434259 |
| 11 | MINK1 | 2.63404223 |
| 12 | GRK6 | 2.51937830 |
| 13 | MAP3K3 | 2.50374491 |
| 14 | MAP3K9 | 2.38862804 |
| 15 | SMG1 | 2.20871731 |
| 16 | MARK3 | 2.19676421 |
| 17 | WEE1 | 2.07906003 |
| 18 | MAP2K3 | 2.06497860 |
| 19 | PLK2 | 1.95748373 |
| 20 | TYK2 | 1.94024692 |
| 21 | MAP2K4 | 1.90379010 |
| 22 | CDK19 | 1.89576118 |
| 23 | DAPK2 | 1.89295976 |
| 24 | SIK1 | 1.82414869 |
| 25 | EEF2K | 1.81050902 |
| 26 | NTRK2 | 1.77544798 |
| 27 | MAP4K1 | 1.69792932 |
| 28 | ICK | 1.68381439 |
| 29 | RIPK4 | 1.63722496 |
| 30 | MAPK13 | 1.63495942 |
| 31 | GRK5 | 1.62207945 |
| 32 | PRPF4B | 1.60492275 |
| 33 | BCR | 1.58068275 |
| 34 | ZAP70 | 1.57624013 |
| 35 | NME2 | 1.54100699 |
| 36 | ARAF | 1.50146582 |
| 37 | RIPK1 | 1.46018329 |
| 38 | BLK | 1.42826335 |
| 39 | CDK5 | 1.38661760 |
| 40 | OXSR1 | 1.38182536 |
| 41 | CDK12 | 1.37245254 |
| 42 | NTRK1 | 1.36911355 |
| 43 | PAK6 | 1.36733065 |
| 44 | DAPK1 | 1.35703691 |
| 45 | KSR1 | 1.33595288 |
| 46 | TSSK6 | 1.31704889 |
| 47 | IRAK3 | 1.30579407 |
| 48 | NME1 | 1.28623129 |
| 49 | PDK4 | 1.27788354 |
| 50 | PDK3 | 1.27788354 |
| 51 | BMPR2 | 1.26560353 |
| 52 | TBK1 | 1.20696988 |
| 53 | PRKCG | 1.19401460 |
| 54 | FES | 1.18976045 |
| 55 | EPHB1 | 1.18201786 |
| 56 | PHKG2 | 1.17530744 |
| 57 | PHKG1 | 1.17530744 |
| 58 | TTN | 1.16900508 |
| 59 | TNK2 | 1.15954196 |
| 60 | PNCK | 1.15119751 |
| 61 | FGFR4 | 1.15011682 |
| 62 | TAOK1 | 1.12806607 |
| 63 | CAMK2A | 1.11501947 |
| 64 | KSR2 | 1.10885882 |
| 65 | PTK2B | 1.10457757 |
| 66 | CAMK2B | 1.10191169 |
| 67 | MAP3K1 | 1.06733573 |
| 68 | IRAK4 | 1.06529110 |
| 69 | UHMK1 | 1.05728801 |
| 70 | EIF2AK1 | 1.05400009 |
| 71 | GRK7 | 1.05327255 |
| 72 | MYLK | 1.05082606 |
| 73 | PDK2 | 1.04476425 |
| 74 | PTK6 | 1.03954538 |
| 75 | MAPK11 | 1.03941503 |
| 76 | WNK3 | 1.03887670 |
| 77 | MAPKAPK3 | 1.03794677 |
| 78 | TNIK | 1.03544532 |
| 79 | SGK223 | 1.00670083 |
| 80 | SGK494 | 1.00670083 |
| 81 | PDPK1 | 1.00330676 |
| 82 | PAK4 | 0.98175641 |
| 83 | SIK2 | 0.96055664 |
| 84 | TAOK2 | 0.95601603 |
| 85 | EPHA2 | 0.95326073 |
| 86 | ERBB3 | 0.94347576 |
| 87 | CDK18 | 0.93542164 |
| 88 | LIMK1 | 0.91853595 |
| 89 | CDK14 | 0.91565919 |
| 90 | PRKD2 | 0.89353227 |
| 91 | PAK3 | 0.87260134 |
| 92 | CDK6 | 0.86453926 |
| 93 | CDK15 | 0.85933662 |
| 94 | STK39 | 0.85868375 |
| 95 | MAP3K2 | 0.85159973 |
| 96 | CCNB1 | 0.84460682 |
| 97 | PRKCE | 0.83401149 |
| 98 | AKT3 | 0.82429077 |
| 99 | SCYL2 | 0.81337174 |
| 100 | MAP3K11 | 0.81312817 |
| 101 | MET | 0.80709304 |
| 102 | PKN2 | 0.79068874 |
| 103 | PKN1 | 0.78881521 |
| 104 | CSNK1G2 | 0.78630652 |
| 105 | PIM2 | 0.77097045 |
| 106 | MARK2 | 0.76956679 |
| 107 | MAP3K14 | 0.75350312 |
| 108 | CAMK2D | 0.72548910 |
| 109 | LMTK2 | 0.72337983 |
| 110 | CDK11A | 0.72021529 |
| 111 | FER | 0.70749902 |
| 112 | ACVR1B | 0.70316549 |
| 113 | CAMKK1 | 0.69487632 |
| 114 | TESK1 | 0.69457346 |
| 115 | SIK3 | 0.68318298 |
| 116 | DYRK1A | 0.67877770 |
| 117 | CAMKK2 | 0.67599959 |
| 118 | KIT | 0.67486103 |
| 119 | ROCK2 | 0.67476930 |
| 120 | MAP2K2 | 0.67270565 |
| 121 | PRKAA2 | 0.66268291 |
| 122 | PRKCH | 0.66262376 |
| 123 | MATK | 0.66080088 |
| 124 | PRKD1 | 0.65944329 |
| 125 | MAP3K13 | 0.65940920 |
| 126 | STK38 | 0.65407998 |
| 127 | FGR | 0.65334296 |
| 128 | MAP3K7 | 0.65218153 |
| 129 | NEK6 | 0.64692399 |
| 130 | ADRBK1 | 0.64676680 |
| 131 | CSNK1G3 | 0.64452474 |
| 132 | MTOR | 0.63541491 |
| 133 | CDK4 | 0.62609918 |
| 134 | CDK7 | 0.61680408 |
| 135 | JAK1 | 0.61408789 |
| 136 | MAP3K10 | 0.60646302 |
| 137 | SGK2 | 0.60392097 |
| 138 | JAK3 | 0.60119125 |
| 139 | LRRK2 | 0.59468577 |
| 140 | CSK | 0.59381134 |
| 141 | SYK | 0.59285368 |
| 142 | DYRK2 | 0.59046352 |
| 143 | FGFR3 | 0.57950909 |
| 144 | DAPK3 | 0.56682425 |
| 145 | PRKD3 | 0.55404070 |
| 146 | RET | 0.55278593 |
| 147 | BTK | 0.53959363 |
| 148 | CAMK2G | 0.53187278 |
| 149 | MAP3K6 | 0.53047153 |
| 150 | MAPK12 | 0.52744587 |
| 151 | AKT2 | 0.52441241 |
| 152 | FYN | 0.51657202 |
| 153 | WNK1 | 0.51646571 |
| 154 | RPS6KA2 | 0.50470201 |
| 155 | MAP2K1 | 0.50399434 |
| 156 | SGK1 | 0.50332527 |
| 157 | TESK2 | 0.49880276 |
| 158 | BRAF | 0.49767485 |
| 159 | ADRBK2 | 0.49682367 |
| 160 | MUSK | 0.49257999 |
| 161 | IRAK2 | 0.49047070 |
| 162 | NEK1 | 0.48784958 |
| 163 | HCK | 0.48682344 |
| 164 | JAK2 | 0.47673349 |
| 165 | PINK1 | 0.47594299 |
| 166 | OBSCN | 0.47590460 |
| 167 | FGFR2 | 0.47112408 |
| 168 | CDC42BPA | 0.45762608 |
| 169 | TYRO3 | 0.45008981 |
| 170 | RAF1 | 0.44839429 |
| 171 | LYN | 0.44837511 |
| 172 | MAPKAPK5 | 0.43119951 |
| 173 | PRKACA | 0.42591766 |
| 174 | MAPK7 | 0.41809478 |
| 175 | PDK1 | 0.41248861 |
| 176 | MAP3K8 | 0.39657337 |
| 177 | SGK3 | 0.38463132 |
| 178 | RPS6KL1 | 0.35081542 |
| 179 | RPS6KC1 | 0.35081542 |
| 180 | CSF1R | 0.33811625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.63016715 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62986630 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.47058815 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.09789928 |
| 5 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.88507477 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71467560 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66965783 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.65612119 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.53446045 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.50751232 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.45962859 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45961168 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42569412 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39778898 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29601007 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15737798 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15565748 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14881547 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11437370 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99164813 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98494819 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.89083639 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.85953038 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83758648 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83271332 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82217300 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80000612 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.79028249 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.77933693 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73201599 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68721029 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.66865365 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.65562573 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.64478408 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.61617640 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61336910 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.60080588 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.58627862 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57176458 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.57003399 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49523604 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48225098 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.46604086 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45179099 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45010604 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42829867 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.40296152 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33869493 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33040809 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32487212 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29392534 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27380153 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27039678 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24020694 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20644127 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 1.20525352 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19772360 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19156304 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.17074714 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16779171 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16197782 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16089390 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14366071 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14348002 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13651975 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13386757 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 1.12895216 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12088148 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.10662234 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10528363 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09597553 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 1.08550225 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 1.07360317 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 1.07082451 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05544548 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03806114 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02244335 |
| 78 | Measles_Homo sapiens_hsa05162 | 1.01644922 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99078066 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97887001 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97139292 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97013014 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95985432 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94204752 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93428048 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92427117 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91324983 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90944768 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90639536 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.89275880 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88866150 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88094797 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88067812 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86714433 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85770115 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85415032 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.85388692 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84616160 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83199984 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82965411 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.82523353 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82396692 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.81771975 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81561131 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.80513686 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77803952 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77076389 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76894239 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76707939 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76167632 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76074234 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75426031 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74825633 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74416789 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72371474 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72348045 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.72316290 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71490732 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.71398938 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70022389 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69752621 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69531503 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69117092 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68302632 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67686567 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67109108 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.66783988 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66534891 |
| 129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64448981 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.64386911 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63451864 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62120915 |
| 133 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60546354 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.60487952 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59641824 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59377164 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58521170 |
| 138 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57728583 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56632879 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56391583 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56384354 |
| 142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55930491 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54641419 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53917514 |
| 145 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51670071 |
| 146 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50664123 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50091773 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49923123 |
| 149 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49767974 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49628793 |
| 151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47994178 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47622482 |
| 153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47538506 |
| 154 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46294465 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.45436108 |
| 156 | Alcoholism_Homo sapiens_hsa05034 | 0.45053834 |
| 157 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42465440 |
| 158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40446449 |
| 159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39468852 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37905612 |
| 161 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36828357 |
| 162 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31039226 |
| 163 | Prion diseases_Homo sapiens_hsa05020 | 0.30866349 |
| 164 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30278511 |
| 165 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30199017 |
| 166 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29153973 |
| 167 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28817521 |
| 168 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28330493 |
| 169 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28164284 |
| 170 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27854435 |
| 171 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27116048 |
| 172 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26626709 |
| 173 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25565623 |
| 174 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24675442 |
| 175 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23609873 |
| 176 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21406981 |
| 177 | Salmonella infection_Homo sapiens_hsa05132 | 0.19855225 |
| 178 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19401700 |
| 179 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18127041 |

